JANUARY 13, 2014
In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits including:
Increased access to patients and experienced investigational sites
Expedited turn-around times
Ability to process complex trials due to qualified staff and skilled facilities
More cost effective than many other countries
Significantly better long term follow-up with patients
Access to high quality medical professionals
Utilizing the effective national health insurance program
Capitalizing on the fact that approximately 80% of the entire population belongs to the same health organization (HMO)
Taking advantage of the well-developed clinical infrastructure where high ethical and informed-consent standards are universally maintained
Are you interested in expanding your studies global footprint into Israel?
Pharm-Olam has proven people and processes in place to help you expand today. Contact us to learn more.